Congenital muscular dystrophy type 1D large gene mutation (Q103689): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
 
(2 intermediate revisions by the same user not shown)
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
16 August 2026
Timestamp+2026-08-16T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 16 August 2026 / rank
 
Normal rank

Latest revision as of 09:26, 17 August 2026

Congenital muscular dystrophy characterised by abnormality in the glycosylation of the alpha-dystroglycan that correlates with an increasingly severe pattern of tissue effects, extending from an adult-onset limb-girdle muscular dystrophy with normal intelligence (LGMD type 2I) to severe congenital brain and eye malformations (Walker–Warburg syndrome). Congenital muscular dystrophy type 1D due to mutations in LARGE is the rarest of the alpha-dystroglycanopathies identified to date. Affected children have typical neurological and muscle abnormalities associated with the alpha-dystroglycanopathies, but with very different severities.
Language Label Description Also known as
default for all languages
ID_987337152
    English
    Congenital muscular dystrophy type 1D large gene mutation
    Congenital muscular dystrophy characterised by abnormality in the glycosylation of the alpha-dystroglycan that correlates with an increasingly severe pattern of tissue effects, extending from an adult-onset limb-girdle muscular dystrophy with normal intelligence (LGMD type 2I) to severe congenital brain and eye malformations (Walker–Warburg syndrome). Congenital muscular dystrophy type 1D due to mutations in LARGE is the rarest of the alpha-dystroglycanopathies identified to date. Affected children have typical neurological and muscle abnormalities associated with the alpha-dystroglycanopathies, but with very different severities.

      Statements

      CID11:ID_987337152
      0 references
      dki-india-ID_987337152
      0 references
      Concluído
      0 references
      16 August 2026
      0 references